MedCity News

Labcorp Is Buying BioReference Health’s Cancer Testing Business for $192M

Labcorp’s latest acquisition brings the oncology testing business of BioReference Health. Opko Health, BioReference’s parent, has been cutting costs to return to profitability. The post Labcorp Is Buying BioReference Health’s Cancer Testing Business for $192M appeared first on MedCity News.

Mar 16, 2025 - 16:21
 0
Labcorp Is Buying BioReference Health’s Cancer Testing Business for $192M

Labcorp’s latest acquisition brings the oncology testing business of BioReference Health. Opko Health, BioReference’s parent, has been cutting costs to return to profitability.

The post Labcorp Is Buying BioReference Health’s Cancer Testing Business for $192M appeared first on MedCity News.

Read More

Tags:

Previous Article

This butterfly-shaped nebula owes its structure to 2 chaotic young stars

Next Article

Vingroup’s Ambitious Green Vision Finds a New Frontier in Indonesia

Related Posts

Buprenorphine Access Still Lags, Even After Major Federal Policy Changes

Buprenorphine Access Still Lags, Even After Major Feder...

Mar 9, 2025  0

‘The Hardest Thing Is Separating the Wheat from the Chaff’: 5 Leaders on the State of Healthcare AI

‘The Hardest Thing Is Separating the Wheat from the Cha...

Feb 24, 2025  0

Denali’s Data in Rare Enzyme Deficiency Keep It on Pace to Seek Speedy FDA Approval

Denali’s Data in Rare Enzyme Deficiency Keep It on Pace...

Feb 9, 2025  0